Prestige Consumer Healthcare

NYSE PBH
$64.73 0.0000 0.0000%
Today share price
USA
Sector: Healthcare Industry: Pharmaceuticals
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Показатель: 34 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.26B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

4.34B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.69
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

50.31M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

5.73 %

Upcoming events Prestige Consumer Healthcare

All events
No upcoming events scheduled

Stock chart Prestige Consumer Healthcare

Stock analysis Prestige Consumer Healthcare

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

15.56 6.77
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

1.97 5.34
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

11.64 19.67
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

2.91 1.40
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

12.65 19.85

Price change Prestige Consumer Healthcare per year

32.20$ 60.57$
Min Max

Summary analysis Prestige Consumer Healthcare

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Prestige Consumer Healthcare

Revenue and net income Prestige Consumer Healthcare

All parameters

About company Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye allergies/redness relief, Compound W wart removals, Debrox ear wax removals, DenTek for PEG oral care, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
Address:
660 White Plains Road, Tarrytown, NY, United States, 10591
Company name: Prestige Consumer Healthcare
Issuer ticker: PBH
ISIN: US74112D1019
Country: USA
Exchange: NYSE
Currency: $
IPO date: 2005-02-10
Sector: Healthcare
Industry: Pharmaceuticals
Site: https://www.prestigebrands.com

On which stock exchange are Prestige Consumer Healthcare (PBH) stocks traded?

Prestige Consumer Healthcare (PBH) stocks are traded on NYSE.

What is the ticker of Prestige Consumer Healthcare stocks (PBH)?

The stock ticker of Prestige Consumer Healthcare’s stocks or in other words, the code is PBH. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Prestige Consumer Healthcare (PBH) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Prestige Consumer Healthcare (PBH) belongs to the «Healthcare» sector and the «Pharmaceuticals» industry.

In what currency are Prestige Consumer Healthcare (PBH) stocks traded?

Prestige Consumer Healthcare (PBH) stocks are traded on the NYSE exchange in dollars.

What is the price of Prestige Consumer Healthcare (PBH) stocks today?

The current price of Prestige Consumer Healthcare stocks on 24.05.2024 is 64.73 dollars. per share.

What is the dynamics of Prestige Consumer Healthcare (PBH) stocks from the beginning of the year?

Prestige Consumer Healthcare (PBH) quotes have increased by 4.42% from the beginning of the year up to 64.73 dollars. per 1 stocks.

How much did Prestige Consumer Healthcare (PBH) stocks increase in мае 2024?

This month Prestige Consumer Healthcare (PBH) quotes have increased by -8.98% to 64.73 dollars. per share.

How much are Prestige Consumer Healthcare (PBH) stocks worth?

Today, on October, 24.05.2024 Prestige Consumer Healthcare’s (PBH) stocks cost 64.73 dollars..

What is the market capitalization of Prestige Consumer Healthcare (PBH)?

Capitalization is the market value of Prestige Consumer Healthcare (PBH) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 24.05.2024, the market capitalization of Prestige Consumer Healthcare (PBH) is estimated at about 3256566300 dollars.